Michael A. Zeligs, M.D., is the Founder and CEO of BioResponse Nutrients and the co-inventor of patented, microencapsulated Diindolylmethane (BioResponse-DIM®). Dr. Zeligs was the first to discover novel nutritional approaches with cruciferous DIM, and has numerous patents for uses of DIM including hormonal health, breast health, and weight loss.
Dr. Zeligs earned a Masters degree in stress-physiology from the University of California, Santa Barbara, and a M.D. degree from the University of California, Irvine, College of Medicine. As a physician-investigator, he has sponsored numerous clinical trials using microencapsulated BioResponse-DIM.
Dr. Zeligs supports clinical trials that are underway using BioResponse DIM in collaboration with Cornell University, the NYU School of Medicine, Cancer Research UK, Wayne State University, and New York Medical College. BioResponse Nutrients works with the National Cancer Institute (NCI) under a clinical trials agreement to discover the further health potential of DIM.
LEARN MORE: About BioResponse Patents... |
